Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Prefrontal tDCS modulates autonomic responses in COVID-19 inpatients.
Brain Stimul. 2023 Mar-Apr;16(2):657-666. doi: 10.1016/j.brs.2023.03.001. Epub 2023 Mar 20.
Brain Stimul. 2023.
PMID: 36940750
Free PMC article.
Clinical Trial.
An increment in oxygen saturation was observed in the active group but not in the sham after the intervention (P = 0.045). There were no group differences regarding mood, incidence and intensity of adverse effects, no occurrence of skin lesions, falls, or clinical worsenin …
An increment in oxygen saturation was observed in the active group but not in the sham after the intervention (P = 0.045). There were …
Cetuximab as third-line rechallenge plus either irinotecan or avelumab is an effective treatment in metastatic colorectal cancer patients with baseline plasma RAS/BRAF wild-type circulating tumor DNA: Individual patient data pooled analysis of CRICKET and CAVE trials.
Martini G, Ciardiello D, Famiglietti V, Rossini D, Antoniotti C, Troiani T, Napolitano S, Esposito L, Latiano TP, Maiello E, Del Re M, Lonardi S, Aprile G, Santini D, Masi G, Avallone A, Normanno N, Pietrantonio F, Pinto C, Ciardiello F, Cremolini C, Martinelli E.
Martini G, et al.
Cancer Med. 2023 Apr;12(8):9392-9400. doi: 10.1002/cam4.5699. Epub 2023 Mar 7.
Cancer Med. 2023.
PMID: 36880426
Free PMC article.
Skin rash was more frequently reported in CAVE trial (87.9% vs. 30.8%; p = 0.001), whereas a increased incidence of hematological toxicities was observed in CRICKET trial (53.8%% vs. 12.1%; p = 0.003). ...
Skin rash was more frequently reported in CAVE trial (87.9% vs. 30.8%; p = 0.001), whereas a increased incidence of hematological tox …
Item in Clipboard
Cite
Cite